Epi Hlth Drug Patent Portfolio
Epi Hlth owns 1 orange book drug protected by 1 US patent Given below is the list of Epi Hlth's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11103517 | Pharmaceutical compositions for minocycline | 07 Apr, 2036 | Active |
Latest Legal Activities on Epi Hlth's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Epi Hlth.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
|
Patent Issue Date Used in PTA Calculation
Critical
| 31 Aug, 2021 | US11103517 |
|
Recordation of Patent Grant Mailed
Critical
| 31 Aug, 2021 | US11103517 |
|
Email Notification
Critical
| 12 Aug, 2021 | US11103517 |
|
Issue Notification Mailed
Critical
| 11 Aug, 2021 | US11103517 |
|
Application Is Considered Ready for Issue
Critical
| 29 Jul, 2021 | US11103517 |
| Dispatch to FDC | 29 Jul, 2021 | US11103517 |
|
Issue Fee Payment Received
Critical
| 26 Jul, 2021 | US11103517 |
|
Email Notification
Critical
| 26 Jul, 2021 | US11103517 |
| Printer Rush- No mailing | 26 Jul, 2021 | US11103517 |
| Mailing Corrected Notice of Allowability | 26 Jul, 2021 | US11103517 |
|
Issue Fee Payment Verified
Critical
| 26 Jul, 2021 | US11103517 |
| Corrected Notice of Allowability | 20 Jul, 2021 | US11103517 |
|
Mail Notice of Allowance
Critical
| 19 Jul, 2021 | US11103517 |
|
Pubs Case Remand to TC
Critical
| 19 Jul, 2021 | US11103517 |
|
Email Notification
Critical
| 19 Jul, 2021 | US11103517 |
Epi Hlth's Family Patents
Epi Hlth drugs have patent protection in a total of 3 countries. It's US patent count contributes only to 50.0% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click
below to unlock the full patent family tree.
Epi Hlth Drug List
Given below is the complete list of Epi Hlth's drugs and the patents protecting them.
1. Minolira
Minolira is protected by 1 patent, which is still active. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US11103517 | Pharmaceutical compositions for minocycline |
07 Apr, 2036
(11 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Minolira's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List